Tenaya Therapeutics, Inc. Common Stock
Symbol: TNYA (NASDAQ)
1.30
▼ (-0.38%) -0.005
Company Description:
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Key Stats
- Today's Open: $1.3
- Today's High: $1.345
- Today's Low: $1.25
- Today's Volume: 2.10M
- Yesterday Close: $1.3
- Yesterday High: $1.38
- Yesterday Low: $1.29
- Yesterday Volume: 3.14M
- Last Min Volume: 1
- Last Min High: $1.295
- Last Min Low: $1.295
- Last Min VWAP: $1.295
Company Profile
- Name: Tenaya Therapeutics, Inc. Common Stock
- Website: https://www.tenayatherapeutics.com
- Listed Date: 2021-07-30
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001858848
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $228.17M
- Round Lot: 100
- Outstanding Shares: 162.98M
- Asset Type: CS
RECENT FILINGS FOR TNYA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-31 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 8-K | View |
| 2025-05-16 | 4 | View |
Latest News on TNYA